RECOMBINANT MURINE PNEUMONIA VIRUS EXPRESSING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE PROTEIN
US Application 19/484,594
Filed on 2025-11-14
Filed on 2025-11-14
Nanoparticle-based Influenza Virus Vaccines and Uses Thereof
Australia
2025230782
Filed on 2025-09-12
2025230782
Filed on 2025-09-12
ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THAT BIND TO MONKEYPOX VIRUSPROTEIN A35 AND VACCINIA VIRUS PROTEIN A33 AND METHODS OF USE
US Application 63/723,296
Filed on 2024-11-21
Filed on 2024-11-21
MYELIN OLIGODENDROCYTE GLYCOPROTEIN, MYELIN BASIC PROTEIN, AND PROTEOLIPID PROTEIN COMPOSITIONS AND METHODS OF USE
US Application 19/352,878
Filed on 2025-10-08
Filed on 2025-10-08
COMPOSITIONS FOR OVERCOMING TETRACYCLINE ANTIBIOTIC RESISTANCE AND
METHODS OF USE THEREOF
US Application 19/313,798
Filed on 2025-08-28
Filed on 2025-08-28
Nanoparticle-Based Influenza Virus Vaccines and Uses Thereof
US Application 19/312,888
Filed on 2025-08-28
Filed on 2025-08-28
Rebalancing the Immune System Through Depletion of Myeloid-Biased Hematopoietic Stem Cells
European Patent
23886580.2
Filed on 2023-10-30
23886580.2
Filed on 2023-10-30
PREFUSION PIV F IMMUNOGENS AND THEIR USE
US Application 19/348,478
Filed on 2025-10-02
Filed on 2025-10-02
RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3
EXPRESSING AVIAN INFLUENZA VIRUS PROTEINS AND USE THEREOF
Patent Cooperation Treaty
PCT/US2025/050239
Filed on 2025-10-09
PCT/US2025/050239
Filed on 2025-10-09
Improved Methods Of Manufacturing Peptide-Based Vaccines
Australia
2025213648
Filed on 2025-08-07
2025213648
Filed on 2025-08-07